SCHEMBL8334528

SCHEMBL8334528

CC(C)([SiH3])C(Cl)(c1ccccc1)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.48
MAPK1 P28482 1/20 0.42
ALDH1A1 P00352 3/20 0.39
CYP1A2 P05177 1/20 0.39
TAAR1 Q96RJ0 1/20 0.39
ALOX15 P16050 1/20 0.39
ESR1 P03372 2/20 0.38
ESR2 Q92731 2/20 0.38
CYP3A4 P08684 1/20 0.38
KCNN4 O15554 3/20 0.37
MAPT P10636 1/20 0.37
KMT2A Q03164 1/20 0.37
CYP2C19 P33261 1/20 0.35
HIF1A Q16665 1/20 0.35
CYP2B6 P20813 1/20 0.34
HDAC3 O15379 1/20 0.34
HDAC4 P56524 1/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC7 Q8WUI4 1/20 0.34
HDAC2 Q92769 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15302768 0.79 TSHR (0.52) TSHRMAPK1ALDH1A1CYP1A2TAAR1
SCHEMBL15275694 0.79 TSHR (0.52) TSHRMAPK1ALDH1A1CYP1A2TAAR1
SCHEMBL10940043 0.78 TSHR (0.65) TSHRMAPK1ALDH1A1CYP1A2TAAR1
SCHEMBL27524798 0.77 TSHR (0.50) TSHRMAPK1ALDH1A1CYP1A2TAAR1
SCHEMBL6036791 0.75 TSHR (0.48) TSHRMAPK1ALDH1A1CYP1A2TAAR1
SCHEMBL28375708 0.75 TSHR (0.48) TSHRMAPK1ALDH1A1CYP1A2TAAR1
SCHEMBL29000452 0.75 TSHR (0.48) TSHRMAPK1ALDH1A1CYP1A2TAAR1
SCHEMBL3805592 0.75 TSHR (0.48) TSHRMAPK1ALDH1A1CYP1A2TAAR1
SCHEMBL2743453 0.73 TSHR (0.58) TSHRMAPK1ALDH1A1CYP1A2TAAR1
SCHEMBL686644 0.73 TSHR (0.58) TSHRMAPK1ALDH1A1CYP1A2TAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4650890-A Preparation of olefinic compounds and intermediates thereof SANDOZ CORP. (US) 1987-03-17 US claimed
US-5952478-A Intermediates for dinucleotide and oligonucleotide analogues NOVARTIS FINANCE CORPORATION (US) 1999-09-14 US disclosed
EP-0778843-A1 INTERMEDIATES FOR DINUCLEOTIDE AND OLIGONUCLEOTIDE ANALOGUES Novartis AG (CH) 1997-06-18 EP disclosed
WO-1996008503-A1 INTERMEDIATES FOR DINUCLEOTIDE AND OLIGONUCLEOTIDE ANALOGUES NOVARTIS AG (CH) 1996-03-21 WO disclosed
US-4841071-A 6-substituted-4-hydroxy-tetrahydropyran-2-ones SANDOZ PHARM. CORP. (US) 1989-06-20 US disclosed
US-4571428-A 6-Substituted-4-hydroxy-tetrahydropyran-2-ones SANDOZ, INC. (US) 1986-02-18 US disclosed